Brooklyn, New York, March 10, 2022 – Opentrons Robotics today announced the largest expansion to date of its automation portfolio with the launch of four new OT-2 workstation products supporting popular applications such as NGS, PCR and protein purification. . These launches build on the success of the OT-2 COVID-19 Workstation, which has been used by hundreds of laboratories around the world to rapidly scale reliable, standardized COVID-19 testing and screening workflows. The new workstation includes the OT-2 platform, application-specific hardware, pipettes and labware, and custom protocol development, enabling any laboratory to quickly establish automated workflows at a fraction of the cost of other automation solutions.
The four new workstations are:
"The expansion of our OT-2 product portfolio will bring the benefits of extremely simple, easy-to-use automation to new customers," said David Kim, general manager of Opentrons Robotics. "Throughout the pandemic, our automation suites have enabled labs to Quickly pivot to COVID-19 testing, screening and genomic surveillance using OT-2 and our modules. In addition to being easy to set up, our solutions help labs run more efficiently – with accurate, reproducible results, all in an automated way that saves scientists time. Bringing all these benefits to scientists working in genomics and proteomics applications."
"The Opentrons system enhances our team's ability to reliably and rapidly obtain purified mRNA, which is critical to our work in developing innovative gene therapies," said Xinyue Zhang, Ph.D., a researcher at Luye Life Sciences in Massachusetts. "The Opentrons team was very supportive and provided custom protocol development that we used for our workflow. Now, preparing the mRNA is as simple as loading the reagents, selecting a protocol and waiting a few hours."
The OT-2 is a high-precision, open-source personal pipetting robot designed to be easy to use by scientists and flexible enough to automate workflows in many applications. The robot and its accompanying automation platform are used to automate hundreds of protocols and workflows in genomics, proteomics, cell-based assays and drug discovery. For more information, please visit: https://opentrons.com/
About Opentrons Labworks, Inc.Opentrons Labworks, Inc. is a disruptive life sciences company using its integrated laboratory platform to accelerate the pace of innovation in research and healthcare. Through our business unit Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use laboratory robots. Health systems across the United States rely on our Pandemic Response Laboratories (PRL) to provide high-throughput, affordable molecular diagnostic testing. Through the recent acquisitions of Neochromosome and Zenith AI, biopharmaceuticals can benefit from our world-class genome-scale cell engineering solutions. For more information, please visit https://www.opentronslabworks.com/.
About Opentrons Robotics, Inc.Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation of life sciences R&D laboratories. Opentrons Robotics' flagship product, the OT-2, is in thousands of labs in more than 40 countries. Throughout the COVID-19 pandemic, OT-2 robots have been deployed to hospital labs around the world to test millions of patient samples. Our expanding product line provides custom automation and protocol development for the most common and time-consuming manual processes in molecular biology, including NGS library preparation, PCR setup, and protein purification. For more information, please visit https://opentrons.com/.
Media ContactMichael Sullivan michael@teamseismic.com
The experienced service team and strong production support team provide customers with worry-free order services.
